BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19836833)

  • 1. The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model.
    Tan ML; Friedhuber AM; Dunstan DE; Choong PF; Dass CR
    Biomaterials; 2010 Jan; 31(3):541-51. PubMed ID: 19836833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.
    Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
    Biomaterials; 2009 Jul; 30(21):3605-13. PubMed ID: 19345993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
    Hu FQ; Liu LN; Du YZ; Yuan H
    Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
    Tan ML; Friedhuber AM; Dass CR
    J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles.
    Kim TH; Mount CW; Gombotz WR; Pun SH
    Biomaterials; 2010 Oct; 31(28):7386-97. PubMed ID: 20598741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.
    Dass CR; Contreras KG; Dunstan DE; Choong PF
    Biomaterials; 2007 Jul; 28(19):3026-33. PubMed ID: 17408737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin.
    Cheng X; Zhang F; Zhou G; Gao S; Dong L; Jiang W; Ding Z; Chen J; Zhang J
    Drug Deliv; 2009 Apr; 16(3):135-44. PubMed ID: 19514973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
    Lee ES; Na K; Bae YH
    J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice].
    Xu XY; Zhou JP; Li L; Zhang Y; Huo MR; Wang X; Lü L
    Yao Xue Xue Bao; 2008 Jul; 43(7):743-8. PubMed ID: 18819480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: doxorubicin delivery systems based on chitosan for cancer therapy.
    Tan ML; Choong PF; Dass CR
    J Pharm Pharmacol; 2009 Feb; 61(2):131-42. PubMed ID: 19178759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin.
    Pastorino F; Di Paolo D; Piccardi F; Nico B; Ribatti D; Daga A; Baio G; Neumaier CE; Brignole C; Loi M; Marimpietri D; Pagnan G; Cilli M; Lepekhin EA; Garde SV; Longhi R; Corti A; Allen TM; Wu JJ; Ponzoni M
    Clin Cancer Res; 2008 Nov; 14(22):7320-9. PubMed ID: 19010847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro experimental study of adriamycin-loaded chitosan drug delivery system].
    Zhang Y; Hou C; Chen A
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1997 Sep; 11(5):309-11. PubMed ID: 9867937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
    Hu FQ; Wu XL; Du YZ; You J; Yuan H
    Eur J Pharm Biopharm; 2008 May; 69(1):117-25. PubMed ID: 17997293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery.
    Lu PL; Chen YC; Ou TW; Chen HH; Tsai HC; Wen CJ; Lo CL; Wey SP; Lin KJ; Yen TC; Hsiue GH
    Biomaterials; 2011 Mar; 32(8):2213-21. PubMed ID: 21176954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of simple chitosan sheet as drug delivery carrier.
    Saito K; Fujieda T; Yoshioka H
    Eur J Pharm Biopharm; 2006 Oct; 64(2):161-6. PubMed ID: 16884897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.
    Ogawara K; Un K; Tanaka K; Higaki K; Kimura T
    J Control Release; 2009 Jan; 133(1):4-10. PubMed ID: 18840484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts.
    Sakakibara T; Chen FA; Kida H; Kunieda K; Cuenca RE; Martin FJ; Bankert RB
    Cancer Res; 1996 Aug; 56(16):3743-6. PubMed ID: 8706018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.